1-(4-(tert-Butyl)phenyl)-4-(4-hydroxypiperidin-1-yl)butan-1-one, 95.0%, 5g

4-[(6-Ethoxy-pyrimidin-4-ylamino)-methyl]-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

(2E)-3-[4-(benzyloxy)phenyl]-1-(4-bromophenyl)prop-2-en-1-one, 95.0%, 2g

trans-2-Nonenal (contains trans-2-Nonenal Diethyl Acetal) (ca. 10% in Ethanol, ca. 0.57mol/L)25mL

3-(3-bromo-1H-1,2,4-triazol-5-yl)propanamide, 5g

6,7-Dihydro-4H-pyrazolo[5,1-c][1,4]oxazine-2-carbaldehyde, 98%, 250mg

Methyl 3-Chloropyrazine-2-carboxylate>98.0%(GC)1g

(6-(Aminomethyl)pyridin-3-yl)boronic acid hydrochloride, 98%, 100mg

3-Butyl-1H-pyrazole-5-carboxylic acid, 250mg

1,4-Phenylenediamine, min. 99%, for synthesis, 100 g, glass packaging

1-Bromo-2,4-difluoro-3-iodobenzene, 98%, 250mg

3-Chloro-2-hydroxy-benzaldehyde, 95.0%, 100g

methyl 3-amino-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95, 10g